Oesophageal cancer is the 8th most common cancer type and the 6th most death causing
cancer type worldwide. One of its subtypes, oesophageal squamous cell carcinoma (OSCC) …

Esophageal squamous cell carcinoma (ESCC) is one of the major global health problems,
especially in Asia. Long non-coding RNAs (lncRNAs) have been increasingly identified and …

Background. Long noncoding RNAs (lncRNAs) have been shown to be involved in the
mechanism of cisplatin resistance in lung adenocarcinoma (LAD). However, the roles of …

Cisplatin (DDP)‑based chemotherapy is the most widely used therapy for non‑small cell lung
cancer (NSCLC). However, the existence of chemoresistance has become a major limitation …

Since its discovery, cisplatin has become the key drug in chemotherapy for cancers.
Nevertheless, chemoresistance in cancers has become an impediment in using cisplatin for …

As a component of p53-dependent lncRNA (long non-coding RNA), PANDAR (the promoter
of CDKN1A antisense DNA damage activated RNA) participates in the epigenetic regulation …

Aberrant expression of long non-coding RNAs (lncRNAs) leads to the development of
chemoresistance by regulating a series of biological processes, which is one of the major …

Esophageal cancer (EC) is one of the most aggressive gastrointestinal cancers. Despite
improvements in therapies, the survival rate of patients with EC remains low. Metastasis …

Intrinsic resistance to ionizing radiation is the major impediment in the treatment and clinical
management of esophageal squamous cell carcinoma (ESCC), leading to tumor relapse …

Emerging evidence has suggested that long noncoding RNAs (lncRNAs) play an essential
role in the tumorigenesis of multiple types of cancer including gastric cancer (GC). However …